These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7344452)

  • 41. Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1'-hydroxyestragole.
    Phillips DH; Miller JA; Miller EC; Adams B
    Cancer Res; 1981 Jan; 41(1):176-86. PubMed ID: 6969628
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of drugs and poisons on the synthesis and activity of microsomal enzymes participating in their metabolism].
    Hanke J
    Folia Med Cracov; 1980; 22(3-4):263-78. PubMed ID: 7026384
    [No Abstract]   [Full Text] [Related]  

  • 43. Carcinogens, drugs, and cytochromes P-450.
    Gelboin HV
    N Engl J Med; 1983 Jul; 309(2):105-7. PubMed ID: 6855860
    [No Abstract]   [Full Text] [Related]  

  • 44. [Human conditioning working in chemical environment].
    Uehleke H
    Clin Ter; 1969 Apr; 49(2):105-18. PubMed ID: 5407312
    [No Abstract]   [Full Text] [Related]  

  • 45. Dose-dependent involvement of intralobular regions of the liver in the biotransformation of xenobiotics.
    Nakatsugawa T; Sherman WK
    Dev Toxicol Environ Sci; 1983; 11():455-8. PubMed ID: 6677486
    [No Abstract]   [Full Text] [Related]  

  • 46. Metabolic capabilities of the human fetus: drug biotransformation.
    Juchau MR
    Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372
    [No Abstract]   [Full Text] [Related]  

  • 47. The possible significance of alkylation in carcinogenesis.
    Magee PN
    N Z Med J; 1968 Jan; 67(426):Suppl:59-72. PubMed ID: 5238939
    [No Abstract]   [Full Text] [Related]  

  • 48. Correlations between sites of chemical modification of DNA, repair, and carcinogenesis.
    Singer B
    Princess Takamatsu Symp; 1982; 12():117-37. PubMed ID: 7166548
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemical carcinogenesis: a view at the end of the first half-century.
    Coombs MM
    J Pathol; 1980 Feb; 130(2):117-46. PubMed ID: 6988556
    [No Abstract]   [Full Text] [Related]  

  • 50. Biochemical basis for dose response relationships in reactive metabolite toxicity.
    Jollow DJ; Roberts S; Price V; Smith C
    Adv Exp Med Biol; 1981; 136 Pt A():99-113. PubMed ID: 7344497
    [No Abstract]   [Full Text] [Related]  

  • 51. The problem of chemically reactive metabolites.
    Gillette JR
    Drug Metab Rev; 1982; 13(6):941-61. PubMed ID: 6754318
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hepatopathies and drugs].
    González Macias J; De Castro del Pozo S
    Rev Esp Enferm Apar Dig; 1974; 44(2):175-86. PubMed ID: 4418081
    [No Abstract]   [Full Text] [Related]  

  • 53. Biotransformation in the liver: implications for human disease.
    Marver HS; Schmid R
    Gastroenterology; 1968 Aug; 55(2):282-9. PubMed ID: 4174553
    [No Abstract]   [Full Text] [Related]  

  • 54. [The effect of cancer on drug metabolism and drug action].
    Lavigne JG
    Sem Hop; 1977 Dec; 53(42):2399-401. PubMed ID: 203040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The biotransformation of drugs.
    Remmer H
    Agressologie; 1982 Jan; 23(A):1-6. PubMed ID: 7081576
    [No Abstract]   [Full Text] [Related]  

  • 56. Biotransformation of chemicals by fish: an overview.
    Lech JJ; Vodicnik MJ
    Natl Cancer Inst Monogr; 1984 May; 65():355-8. PubMed ID: 6462196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The carcinogenicity of anticancer drugs: a hazard in man.
    Harris CC
    Cancer; 1976 Feb; 37(2 Suppl):1014-23. PubMed ID: 766951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Liver lesions caused by drugs and environmental pollutants. Free radicals and reactive metabolites. I].
    Mariani L; Baratelli M
    Clin Ter; 1982 Nov; 103(3):237-65. PubMed ID: 7151380
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug metabolism and effects of carcinogens in cultured hepatic cells.
    Sirica AE; Pitot HC
    Pharmacol Rev; 1979 Sep; 31(3):205-28. PubMed ID: 399684
    [No Abstract]   [Full Text] [Related]  

  • 60. Novel uses of mass spectrometry in studies of adducts of alkylating agents with nucleic acids and proteins.
    Farmer PB; Lamb J; Lawley PD
    IARC Sci Publ; 1988; (89):347-55. PubMed ID: 3198219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.